During the past decade, Universitätsklinikum Jena conducted 159 clinical trials. In the 10-year time frame, 159 clinical trials started and 68 clinical trials were completed, i.e. on average, 42.8% percent of trials that started reached the finish line to date. In the past 5 years, 63 clinical trials started and 51 clinical trials were completed. i.e. 81% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsklinikum Jena" #1 sponsor was "Celgene" with 11 trials, followed by "Boehringer Ingelheim" with 9 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 7 trials sponsored, "Universitätsklinikum Hamburg-Eppendorf" with 6 trials sponsored and "Abbott Medical Devices" with 6 trials sponsored. Other sponsors include 201 different institutions and companies that sponsored additional 138 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Jena" #1 collaborator was "Merck Sharp & Dohme LLC" with 5 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator, "Hoffmann-La Roche" with 4 trials as a collaborator, "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 3 trials as a collaborator and "Gilead Sciences" with 3 trials as a collaborator. Other collaborators include 172 different institutions and companies that were collaborators in the rest 160 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Jena" are "Crohn's Disease" (9 trials), "Amyotrophic Lateral Sclerosis" (8 trials), "Heart Failure" (8 trials), "Ovarian Cancer" (7 trials) and "Multiple Myeloma" (6 trials). Many other conditions were trialed in "Universitätsklinikum Jena" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Jena" are "Drug" (169 trials), "Device" (35 trials), "Biological" (32 trials), "Other" (27 trials) and "Procedure" (21 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (52 trials), "Pembrolizumab" (7 trials), "cyclophosphamide" (7 trials), "radiation therapy" (7 trials) and "Dexamethasone" (6 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Jena" are 221 trials for "All" genders, 15 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Universitätsklinikum Jena". undefined are not yet recruiting, 40 are recruiting, 48 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 118 completed trials in Universitätsklinikum Jena, 2 suspended trials, and 24 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Jena, 9 "Phase 1" clinical trials were conducted, 64 "Phase 2" clinical trials and 112 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 23 trials that are defined as “Not Applicable".

Universitätsklinikum Jena has several departments that took part in Clinical trials: "Universitätsklinikum Jena; Klinik für Innere Medizin II" - 10 trials, "Department of Neurology, Universitaetsklinikum Jena" - 5 trials, "Universitätsklinikum Jena, Klinik für Innere Medizin III" - 4 trials, "Gemeinschaftspraxis Innere Medizin" - 3 trials, "Department of Neurology, University of Jena" - 3 trials, "Universitaetsklinikum Jena Klinik fuer Kinder- und Jugendmedizin Neuropaediatrie" - 2 trials, "Universitätsklinikum Jena und Poliklinik für Urologie" - 2 trials, "Department of Urology, University Hospital Jena" - 2 trials, "Universitätsklinikum Jena Klinik für Innere Medizin I" - 2 trials, "University Hospital Jena, Radiology" - 2 trials, "Klinik für Herz- und Thoraxchirurgie, Universitätsklinikum Jena" - 2 trials